Mali Gets Deal on Western HIV Drugs
April 9, 2001
The government of Mali said it has reached a deal for an 89 percent cost cut in HIV drugs from Bristol-Myers Squibb, GlaxoSmithKline, Boehringer-Ingelheim and Merck Sharp and Dohme. The deal lower the cost of treatment from $485 to $85 per month. An estimated 130,000 of the African nation's 11 million citizens are living with AIDS. The government plans subsidies of up to 100 percent for the poorest patients.Adapted from:
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.